NanoString Technologies Company
NanoString Technologies provides a life science tools platform for a variety of basic research, translational medicine and IVD applications.
Technology:
Genetic Test & Molecular Diagnostics
Industry:
Omic
Headquarters:
Seattle, Washington, United States
Founded Date:
2003-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
13
Total Funding:
$731,350,000.00
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-10-13
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership